ME Therapeutics Holdings Inc.

4 videos on CSE TV

ME Therapeutics (CSE:METX)Engineering Immune Cells to Fight Cancer
Jun 1, 2026CSE Listed Issuer Updates
Targeting Immune Suppression in Cancer TreatmentIssuer Update (CSE:METX)
Aug 18, 2025CSE Listed Issuer Updates
ME Therapeutics Holdings Inc. (CSE:METX) Opens the MarketApril 17th, 2024
Apr 17, 2024CSE Market Open
Salim Dhanji on Targeting Immune Suppression in Cancer
Mar 25, 2024Newly Listed on the CSE

A Personal Mission to Reprogram the Human Immune Response to CancerOften when we discuss life sciences, particularly as investors, the human element gets lost. The focus tends to be on the pipeline, clinical and preclinical progress, data, efficacy, cash runway, and addressable market. These and other inputs can be plugged into a model to provide insight into a company’s chance of success. But this process…
Jan 7, 2026CSE Issuer StoriesME Therapeutics Holdings Inc. (CSE:METX)